Elite Pharmaceuticals ELTP
OTC ELTP
$0.25 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Elite Pharmaceuticals (ELTP) Return on Assets [ROA] (2011 - 2026)

Updated

Elite Pharmaceuticals' Return on Assets [ROA] was 40.77% in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 51.27 percentage points from -10.50% a year earlier and up 6.87 percentage points from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Return on Assets [ROA] (2011 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Return on Assets [ROA] at Elite Pharmaceuticals came in at 38.24%, up 43.13 percentage points from FY2025.

  • Return on Assets [ROA] shows a five-year change of +22.04 percentage points (FY2021 to FY2026).
  • In earlier fiscal years, Return on Assets [ROA] was -4.89% in FY2025 (-37.24 pp), 32.35% in FY2024 (+22.98 pp), 9.37% in FY2023 (-16.85 pp) and 26.22% in FY2022 (+10.01 pp).
  • The fiscal Q1 2027 figure marks the highest quarterly Return on Assets [ROA] since fiscal Q1 2016.
  • Compared with a year earlier, Return on Assets [ROA] has increased for four straight quarters, with an average year-over-year change of +2.78 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Assets [ROA] over five years was fiscal Q3 2026 (a gain of 55.62 percentage points); the worst was fiscal Q3 2025 (a drop of 41.45 percentage points).
  • Per Business Quant data, ELTP's Return on Assets [ROA] in the three fiscal quarters before Q1 2027 was 33.90% (Q4 2026), 35.56% (Q3 2026) and 12.11% (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 8.08%
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 4.65%
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 2.45%
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 10.60%
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 9.10%
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 9.29%
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -6.13%
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 2.14%
10 Elite Pharmaceuticals 269.28 Mn 150.96 Mn 13.51 Mn 40.77%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 40.77%
Mar 31, 2026 33.90%
Dec 31, 2025 35.56%
Sep 30, 2025 12.11%
Jun 30, 2025 -10.50%
Mar 31, 2025 -4.70%
Dec 31, 2024 -20.06%
Sep 30, 2024 -7.22%
Jun 30, 2024 22.88%
Mar 31, 2024 25.44%
Dec 31, 2023 21.39%
Sep 30, 2023 30.40%
Jun 30, 2023 10.06%
Mar 31, 2023 7.61%
Dec 31, 2022 14.01%
Mar 31, 2022 23.97%
Dec 31, 2021 16.40%
Sep 30, 2021 16.03%
Jun 30, 2021 19.74%
Mar 31, 2021 18.55%
API Access

Elite Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ELTP&period=max&api_key=YOUR_API_KEY